Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
Healthcare stocks have gotten crushed in 2024, and next year doesn’t look much better. But there are still opportunities for ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...
Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years.
Citi analysts forecast 19% earnings growth for the healthcare sector in 2025 amid improving fundamentals and a boom in weight loss drugs.
Elon Musk, 53, shared on Wednesday that he uses Mounjaro, a weight-loss medication, after previously endorsing similar drugs ...
Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...
Dec. 10, 2024 — New research shows that mothers have twice the impact on language exposure, challenging traditional parenting advice. In a new study, researchers found that there wasn't a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback